Literature DB >> 25849275

Corrigendum: Asfotase-α improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1.

Jean de la Croix Ndong, Alexander J Makowski, Sasidhar Uppuganti, Guillaume Vignaux, Koichiro Ono, Daniel S Perrien, Simon Joubert, Serena R Baglio, Donatella Granchi, David A Stevenson, Jonathan J Rios, Jeffry S Nyman, Florent Elefteriou.   

Abstract

Entities:  

Year:  2015        PMID： 25849275     DOI： 10.1038/nm0415-414c

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  1 in total

1.  Asfotase-α improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1.

Authors:  Jean de la Croix Ndong; Alexander J Makowski; Sasidhar Uppuganti; Guillaume Vignaux; Koichiro Ono; Daniel S Perrien; Simon Joubert; Serena R Baglio; Donatella Granchi; David A Stevenson; Jonathan J Rios; Jeffry S Nyman; Florent Elefteriou
Journal:  Nat Med       Date:  2014-07-06       Impact factor: 53.440
  1 in total
  2 in total

Review 1.  Hypophosphatasia: Biological and Clinical Aspects, Avenues for Therapy.

Authors:  Jean Pierre Salles
Journal:  Clin Biochem Rev       Date:  2020-02

2.  Liraglutide attenuates the osteoblastic differentiation of MC3T3‑E1 cells by modulating AMPK/mTOR signaling.

Authors:  Xiong-Ke Hu; Xin-Hua Yin; Hong-Qi Zhang; Chao-Feng Guo; Ming-Xing Tang
Journal:  Mol Med Rep       Date:  2016-09-06       Impact factor: 2.952
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.